No evidence of decreased artemisinin efficacy in a high-transmission malaria setting in Mali

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 1, 2012, Pages 16-17

  Ng, Caroline L ^a   Fidock, David A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE;

BLOOD SMEAR; CLINICAL STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESISTANCE; EDITORIAL; FEVER; HUMAN; IMMUNITY; IN VITRO STUDY; MALARIA FALCIPARUM; MALI; PARASITE CLEARANCE;

ANTIMALARIALS; ARTEMISININS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE;

EID: 84863758954     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.12-0344     Document Type: Editorial

References (21)

1. White NJ, 2008. Qinghaosu (artemisinin): the price of success. Science 320: 330-334. (Pubitemid 351555649)
2. World Health Organization, 2010. Guidelines for the Treatment of Malaria, 2nd Ed. Geneva: World Health Organization.
3. Eastman RT, Fidock DA, 2009. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7: 864-874.
4. Feachem R, Sabot O, 2008. A new global malaria eradication strategy. Lancet 371: 1633-1635.
5. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
6. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
7. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379: 1960-1966.
8. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4: e4551.
9. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209-218. (Pubitemid 34464751)
10. Crawley J, Chu C, Mtove G, Nosten F, 2010. Malaria in children. Lancet 375: 1468-1481.
11. Wells TN, Alonso PL, Gutteridge WE, 2009. New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov 8: 879-891.
12. Flegg JA, Guerin PJ, White NJ, Stepniewska K, 2011. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 10: 339.
13. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ, 2010. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 201: 570-579.
14. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ, 2012. A major genome region underlying artemisinin resistance in malaria. Science 336: 79-82.
15. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimde AA, 2012. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg 87: 23-28.
16. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G, 2012. Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Trop 121: 227-239.
17. Beez D, Sanchez CP, Stein WD, Lanzer M, 2011. Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother 55: 50-55.
18. Tucker MS, Mutka T, Sparks K, Patel J, Kyle DE, 2012. Phenotypic and genotypic analysis of in vitro-selected artemisininresistant progeny of Plasmodium falciparum. Antimicrob Agents Chemother 56: 302-314.
19. Witkowski B, Lelievre J, Barragan MJ, Laurent V, Su XZ, Berry A, Benoit-Vical F, 2010. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 54: 1872-1877.
20. O'Brien C, Henrich PP, Passi N, Fidock DA, 2011. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 24: 570-577.
21. Guerin PJ, Bates SJ, Sibley CH, 2009. Global resistance surveillance: ensuring antimalarial efficacy in the future. Curr Opin Infect Dis 22: 593-600.